Related Experiment Video
Updated: Jun 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes
Hiroki Ikeda1, Yoshiyuki Hamamoto, Sachiko Honjo
1Center for Diabetes & Endocrinology, The Tazuke Kofukai Foundation Medical Research Institute Kitano Hospital, Osaka, Japan.
Abstract:
We investigated the effect of olmesartan on early diabetic nephropathy in hypertensive patients with type 2 diabetes by its replacement of other angiotensin II type 1 receptor blockers (ARBs) by olmesartan. The urinary albumin/creatinine ratio significantly decreased. The present result suggests a possibility that olmesartan may have more effect on early nephropathy than other ARBs.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Nephrotic Syndrome II : Assessment and Medical Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Diabetic Nephropathy
Antihypertensive Drugs: Action of Diuretics
